AcelRx (Nasdaq: ACRX) is positive Wednesday after announcing late Tuesday that the primary endpoint was met in a placebo-controlled Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE